Company intelligence / Profile preview

BioFluidica

San Diego, California, United Statesbiofluidica.com ↗

Ownership: Private
Development stage: Commercial

Overview

BioFluidica has developed a revolutionary liquid biopsy platform that has been clinically tested on nine different cancer and prenatal patient samples. Their technology is currently used for research applications to advance the field of liquid biopsy.

Therapeutic areas: OncologyWomen's Health
Modalities: Liquid biopsy technology
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on BioFluidica.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioFluidica.

Explore the full profile